📇 Rhumatologue · ISSY LES MOULINEAUX · (92) · Libéral

MME DORA LEVY-ABDULGHANI

Pourquoi vous devez consulter ce praticien

2 raisons identifiées

Auteur de référence en rhumatologie
29 articles scientifiques publiés — un praticien à la pointe de la recherche
Délais de RDV courts dans la région
136 rhumatos / 100 000 hab. — département bien doté

Rhumatologue

📍 ISSY LES MOULINEAUX (92)LibéralRPPS 10001066553

✨ Génération du profil synthétique IA en cours…

Lieu de consultation

CABINET DU DR DORA LEVY-ABDULGHANI
166 AVENUE DE VERDUN, 92130 ISSY LES MOULINEAUX
☎ 46429500Activité de soin et de pharmacie

Tarifs & secteur de conventionnement

Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).

📊 Comprendre le remboursement

Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.

Top publications · les plus citées

Gut microbiome changes and cancer immunotherapy outcomes associated with dietary interventions: a systematic review of preclinical and clinical evidence

Journal of translational medicine · 2025

📚 12 citations🎯 RCR 4.12🔓 Open Access

Lire l'abstract Crossref ↓

Abstract Introduction Cancer patient’s survival has gradually improved due to immune checkpoint inhibitors (ICIs). Several studies showed a possible association between the intestinal microbiome and ICI efficacy. Strategies for modifying the composition of the gut microbiome encompass various dietary interventions, which may have distinct impacts on the outcomes of ICI-treated patients. In our systematic review, we explored how dietary habits correlate with therapeutic responses in cancer patients and cancer mouse models undergoing immunotherapy. Methods A systematic review was conducted using search terms: “cancer”, “immunotherapy”, “diet”, and “microbiome”, from Medline, Web of Science, Scopus, and Cochrane Library databases. The outcomes in the clinical studies were overall response rate (ORR), overall survival (OS), or progression-free survival (PFS) in human studies. In mouse studies, change in tumor size was the endpoint. The comparator attributions were questionnaire-based dietary interventions. Results Nineteen articles met the inclusion criteria and were included in the review (6 prospective cohort studies, 1 cross-sectional observational study, and 12 mouse studies). A consistent association was observed between high (vs. low) fiber consumption and improved therapeutic response with a pooled odds ratio of 5.79 when including all human prospective cohort studies. In mice, limited availability of methionine, cysteine, and low intake of leucine and glutamine was linked to reduced tumor progression. Combining ICIs with intermittent fasting or a fasting-mimicking diet significantly decreased tumor volume in mouse melanoma models. In humans, a higher relative abundance of short-chain fatty acid (SCFA) and lactic acid-producing bacteria—particularly Faecalibacterium prausnitzii and Akkermansia muciniphila—correlated with objective response rates (ORR). Similar microbiome alterations were observed in mouse models. Increased fiber intake enhanced ICI efficacy in mice by modulating the gut microbiome, primarily via elevated SCFA production—an effect also reflected in human studies. Conclusion Intermittent fasting, high fiber, and low sugar consumption are significantly associated with better ICI outcomes. The studies revealed alterations in microbiota composition linked to diet, and these findings were confirmed in animal models, regarding the production of SCFAs and lactic acid, as well as an increase in Bacteroidota/Bacillota ratio and microbial diversity.

Expanding the role of exosomes in drug, biomolecule, and nanoparticle delivery

Life sciences · 2025

📚 11 citations🎯 RCR 4.58

A review on biomacromolecular ligand-directed nanoparticles: New era in macrophage targeting

International journal of biological macromolecules · 2025

📚 4 citations

Cookies & analyse de trafic

MME DORA LEVY-ABDULGHANI

Pourquoi vous devez consulter ce praticien

Lieu de consultation

Tarifs & secteur de conventionnement

Prendre rendez-vous & contact

Top publications · les plus citées

Publications scientifiques (29) — classées par pathologie

Transversal11

Revue générale6

Pédiatrie3

Revue / méta-analyse3

Case report / série2

csDMARDs2

Essai clinique2

Épidémiologie & registres1

IA en rhumatologie1

IRM ostéo-articulaire1

Microbiote1

Santé mentale / fatigue1

Partager cette fiche